Visit coronavirus.gov for the latest Coronavirus Disease (COVID-19) updates.

You are here

Evidence-Based Resource Summary

Strength of Evidence: 
3 out of 4
3 out of 4
Year Published: 
2015

National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology – Genetic and Familial High-Risk Assessment: Breast and Ovarian Cancer

Description of Resource: 
This resource contains evidence-based guidelines from the National Comprehensive Cancer Network on BRCA genetic testing for hereditary breast and ovarian cancer.

Evidence-Based Resource Details

help Learn more about EBR criteria
Developed By: 
National Comprehensive Cancer Network
Developer Type: 
Non-Federal Government
Healthy People 2020 Topic Area(s): 
Genomics
Healthy People 2020 Objectives: 
Resource Type: 
Non-Systematic Review
Expert Opinion
Citation: 
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian, version 2 [Internet]. 2015 Jun [cited 2015 Jul 6]. Available from: http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf